Relative Aggrecan mRNA expression levels, as measured by qPCR, in lentiviral-transduced control cells and 5 AggKD cell lines confirm decreased Aggrecan expression in the AggKD cell... by Juanita K. Hodax (6848540)

Decreased tumorigenicity of A549 cells <i>in vivo</i> with reduced IQGAP3 expression. by Ying Yang (24175)

Expression and stability of EspA are decreased in the absence of <i>escA.</i> by Ching-Nan Lin (508587)

Real-time PCR confirmation of randomly selected genes whose expression levels were either increased (red) or decreased (green) by a specific endoxifen concentration. by John R. Hawse (227611)

“…Darkly shaded bars depict relative fold changes from E₂ (10 nM), TAM (300 nM), 4HT (7 nM) and NDT (700 nM) treated cells (combo/dashed line) as detected by microarray analysis while lightly shaded bars depict fold change as detected by RT-PCR analysis. …”

<i>Cbp</i> inhibition decreases hypothalamic glycolytic markers. by Cesar L. Moreno (3341927)

<i>Clec7a</i> expression is decreased with age in tail skin but increased by age in heart and lung from CB6F1 mice. by William R. Swindell (175427)

A genetic deficit in endothelial c-kit expression decreases colony-forming VESCs and results in impaired EC proliferation and angiogenesis, and retardation of tumor growth in vivo. by Shentong Fang (127331)

Decrease in levels of <i>Sox2</i> expression delays prosensory specification. by Lu M. Yang (6919364)

Meltrin β does not affect the expression of EphA4 on the cell surface nor the initial association between ephrin-A5 and EphA4, but decreases accessibility of antibodies that recognize the EphA4 C-terminus. by Norihiro Yumoto (270290)

Subjects:

The decrease of ULK1 expression by miR-17-5p from BCG infection. by Xiangguo Duan (423329)

TG mice hearts show decreased ISO response. by Mayilvahanan Shanmugam (691549)

Fig 5 - by Dennis Ochola (11626912)

Subjects:

Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric <i>in silico</i> ROCOCO trial by Daniëlle B. P. Eekers (5560430)

Blocking NKp44 interaction decreases the release of IFN-γ. by Kelly E. Bowen (4857370)

Inhibition of TGF-β decreases endothelial barrier function in vivo. by Tony E. Walshe (269700)

“…Scale = 0.5 µm. (D) Immunoprecipitation of occludin and western blotting for zo-1 demonstrated a significant decrease in association between occludin and zo-1 in lysates prepared from retinas of sEng-expressing mice (day 7). …”

Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival. by Chien-Yu Huang (802982)

Compromised ROS response and stop-codon recoding with decreased Gpx and TrxR1 protein levels and activity in <i>Alkbh8</i>^<i>-/-</i> MEFs. by Lauren Endres (765718)

Argon-mediated decrease of apoptosis is attenuated following ERK1/2 and TLR inhibition. by Felix Ulbrich (678720)

Decrease of NF-κB activity in tumor tissue of CCR5^−/− mice. by Ju Kyoung Song (324058)

“…<p><b>A</b>, The DNA binding activity of NF-κB was determined in the nuclear extracts of the CCR5^−/− mice and CCR5^+/+ mice tumor tissues by EMSA described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033747#s4" target="_blank">material and methods</a>. …”

CD154 blockade decreases CXCL1, CCL3, and CCL5 expression in allografts. by Ivana R. Ferrer (317062)